Simcere Pharmaceutical Group. announced the resignation of Mr. Hong Zhao, an executive vice president of the Company. His resignation has been accepted by the company and will take into effect on April 1, 2013.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
5.83 HKD | -2.35% | -6.12% | -13.37% |
06-03 | Simcere Pharmaceutical’s Cancer Drug Shows Positive Results | MT |
06-03 | Simcere Pharma Presents Results of Phase 3 Trial for Anti-Cancer Injection at US Oncology Society Meeting | MT |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-13.37% | 1.95B | |
+19.75% | 43.46B | |
+24.43% | 22.61B | |
+17.44% | 15.15B | |
+23.52% | 14.83B | |
+58.10% | 13.08B | |
-0.05% | 6.79B | |
-12.44% | 6.72B | |
-8.87% | 5.73B | |
+12.71% | 5.45B |
- Stock Market
- Equities
- 2096 Stock
- News Simcere Pharmaceutical Group Limited
- Simcere Pharmaceutical Group. Announces Resignation of Hong Zhao as Executive Vice President, Effective from April 1, 2013